The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease
about
Effects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysisAPOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean populationEffects of a 3-year dietary intervention on age-related changes in triglyceride and apolipoprotein A-V levels in patients with impaired fasting glucose or new-onset type 2 diabetes as a function of the APOA5 -1131 T > C polymorphism.Association of two common polymorphisms of apolipoprotein A5 gene with metabolic syndrome indicators in a North Iranian population, a cross-sectional study.Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects.Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease.Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.Study design and rationale of "Synergistic effect of combination therapy with cilostazol and ProbUcol on plaque stabilization and lesion REgression (SECURE)" study: a double-blind randomised controlled multicenter clinical trialAssociation of the Apolipoprotein A5 Gene -1131T>C Polymorphism with Serum Lipids in Korean Subjects: Impact of Sasang Constitution.Positive Association between APOA5 rs662799 Polymorphism and Coronary Heart Disease: A Case-Control Study and Meta-AnalysisApolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.Apolipoprotein polymorphism is associated with pro-thrombotic profile in non-demented dyslipidemic subjects.The APOA5 rs662799 polymorphism is associated with dyslipidemia and the severity of coronary heart disease in Chinese women.Decreased activities of apolipoprotein m promoter are associated with the susceptibility to coronary artery diseases.Adaptive genetic variation and heart disease risk.Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.Apolipoprotein A5 gene variants and the risk of coronary heart disease: a case‑control study and meta‑analysis.Association of APOA5 T1131C polymorphism and risk of coronary artery disease.A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.The Association Between APOA5 Gene Polymorphisms and Plasma Lipids in the Turkish Cypriot Population: A Possible Biomarker for Preventing Cardiovascular Diseases.Genetically elevated levels of circulating triglycerides and brachial-ankle pulse wave velocity in a Chinese population.Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.Elevated levels of triglyceride and triglyceride-rich lipoprotein triglyceride induced by a high-carbohydrate diet is associated with polymorphisms of APOA5-1131T>C and APOC3-482C>T in Chinese healthy young adults.Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke.Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
P2860
Q28286797-56A66F39-0897-4F7A-AFD4-1F20B6B99648Q28302513-3A998CD4-A8A0-42FF-BE2A-5CCE37EABE33Q33574568-B1058E44-4763-4FA9-ADD4-E74210096B2DQ33649101-6300927B-7C3D-44C0-A4D2-73D21BD471C9Q33653008-C9C660E5-80A7-482E-9EFF-EF7F61DCB146Q34188057-ABB39DA3-02C7-431F-8610-6FE71B7E6FA3Q34318279-AB6B31D4-DFFE-4735-A3DF-731F1BAEF3A5Q34552698-F63FDCAF-38EA-460E-81FA-22D735238371Q35167954-D120EC14-E64D-4375-B9A5-550F34097E28Q35756304-75F1E209-FEE7-4F9A-B1F9-FC8CF6A7AF26Q36073931-297AB6B1-7577-49EA-BFFF-867425F45EAAQ37070957-527C63CC-F1C1-4F44-AFE6-69EFE3869629Q37319745-0BF4EDF6-9978-47FA-AA5A-78593BDB68E2Q37605404-3C25D362-92EC-46E9-8856-B91BEF299530Q37605853-A1275BE3-C35D-4024-BBB2-2AE35FCB9D1DQ37682045-5F17020C-167D-4082-83F3-FF11C0E8CD67Q37693916-7DF0FA9A-F818-465F-A326-82AFC185C3A3Q42536096-490C2E64-A736-4734-AE15-C5FC346342B5Q47164479-A5E09737-5343-4DCC-B21B-D3BF23CDF5C9Q47561874-2E2D6DDE-7DD1-41FB-88E9-83B031CCF71CQ47683577-3B163B80-EF87-4051-9AB6-07E8F0B88521Q48897669-2154B4FB-B713-43DB-8097-AC195E7EC947Q51372370-CD6C3319-5CDF-48F4-ABCF-C4DCE9D08885Q54287698-2EBF804E-EAF5-46F5-A269-D99A5DDBC9C4Q55119107-3DB7847F-9DD9-42D6-9DEF-E509FD438237
P2860
The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The apolipoprotein A5 -1131T>C ...... ze and coronary artery disease
@ast
The apolipoprotein A5 -1131T>C ...... ze and coronary artery disease
@en
type
label
The apolipoprotein A5 -1131T>C ...... ze and coronary artery disease
@ast
The apolipoprotein A5 -1131T>C ...... ze and coronary artery disease
@en
prefLabel
The apolipoprotein A5 -1131T>C ...... ze and coronary artery disease
@ast
The apolipoprotein A5 -1131T>C ...... ze and coronary artery disease
@en
P2093
P2860
P1433
P1476
The apolipoprotein A5 -1131T>C ...... ze and coronary artery disease
@en
P2093
Dong-Jik Shin
Jean Kyung Paik
Jey Sook Chae
Ji Young Kim
Jong Ho Lee
Ju Ree Choi
Sang Hak Lee
Yae Jung Hyun
P2860
P356
10.1016/J.CCA.2008.12.024
P577
2008-12-31T00:00:00Z